Permanent His-bundle pacing using distal His-bundle electrogram-guided approach in patients with atrioventricular

Kazumasa Suga1,2, Hiroyuki Kato1, Yasuya Inden2

  • 1Division of Cardiology, Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Japan.

Insights

This study shows that targeting a distal His-bundle electrogram (HBE) during His-bundle pacing (HBP) improves success rates, especially for patients with infranodal block. This technique offers feasible and stable pacing for atrioventricular block.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Permanent His-bundle pacing (HBP) is an effective and safe pacing strategy.
  • However, HBP implantation success rates are often limited, particularly in patients with infranodal block.
  • This highlights the need for improved HBP techniques.

Purpose of the Study:

  • To evaluate the efficacy and feasibility of His-bundle pacing (HBP) implantation using an electrophysiological guided approach.
  • The study specifically targeted a distal His-bundle electrogram (HBE) in patients diagnosed with atrioventricular block (AVB).

Main Methods:

  • Thirty-four patients with AVB, including 28 with infranodal block, underwent HBP implantation.
  • A unipolar mapping technique was employed to target the distal HBE, aiming to pace beyond the block site.
  • His-capture thresholds were monitored for one year post-implantation.

Main Results:

  • Successful HBP was achieved in 26 patients (76.5%), with 21 of 28 patients (75%) with infranodal block achieving successful pacing.
  • Detection of a distal HBE was significantly more frequent in the successful HBP group (65.4%) compared to the failure group (0%, p=0.001).
  • Among patients with intra-Hisian block, 93% achieved successful HBP with distal HBE detection. A higher implantation His-capture threshold and less distal HBE detection predicted future increases in threshold.

Conclusions:

  • His-bundle pacing (HBP) guided by a distal His-bundle electrogram (HBE) approach appears feasible.
  • This technique may lead to stable pacing outcomes in patients suffering from intra-Hisian and atrioventricular nodal block.
  • Targeting distal HBE is crucial for successful HBP in challenging AVB cases.
Abstract

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
180
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
204
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
164
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.6K
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.0K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.2K